Mitiglinide is a drug for the treatment of type 2 diabetes. It may stimulate insulin secretion in beta-cells by closing off ATP dependant potassium ion channels.
用于改善2型糖尿病患者餐后高血糖(仅限用于经饮食、运动疗法不能有效控制血糖的患者或在饮食、运动疗法的基础上加用α-葡萄糖苷酶抑制剂后仍不能有效控制血糖的患者)。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.